Exact Therapeutics Shares Owned By Insiders vs. Book Value Per Share
| EXTX Stock | NOK 3.60 0.20 5.26% |
For Exact Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Exact Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Exact Therapeutics AS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Exact Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Exact Therapeutics AS over time as well as its relative position and ranking within its peers.
Exact |
Exact Therapeutics Book Value Per Share vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Exact Therapeutics's current stock value. Our valuation model uses many indicators to compare Exact Therapeutics value to that of its competitors to determine the firm's financial worth. Exact Therapeutics AS is one of the top stocks in shares owned by insiders category among its peers. It also is one of the top stocks in book value per share category among its peers creating about 0.04 of Book Value Per Share per Shares Owned By Insiders. The ratio of Shares Owned By Insiders to Book Value Per Share for Exact Therapeutics AS is roughly 24.71 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Exact Therapeutics' earnings, one of the primary drivers of an investment's value.Exact Book Value Per Share vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Exact Therapeutics |
| = | 64.13 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Exact Therapeutics |
| = | 2.60 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Exact Book Value Per Share Comparison
Exact Therapeutics is currently under evaluation in book value per share category among its peers.
Exact Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Exact Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Exact Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Exact Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Exact Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
EXACT Therapeutics AS, a clinical stage biotech company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy . The company was founded in 2012 and is based in Oslo, Norway. EXACT THERAPEUTICS is traded on Oslo Stock Exchange in Norway.
Exact Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Exact Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Exact Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Exact Therapeutics' important profitability drivers and their relationship over time.
Use Exact Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Exact Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exact Therapeutics will appreciate offsetting losses from the drop in the long position's value.Exact Therapeutics Pair Trading
Exact Therapeutics AS Pair Trading Analysis
The ability to find closely correlated positions to Exact Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Exact Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Exact Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Exact Therapeutics AS to buy it.
The correlation of Exact Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exact Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exact Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Exact Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Exact Therapeutics position
In addition to having Exact Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Millennials Best Thematic Idea Now
Millennials Best
Companies or funds that provide products or services that appeal to the generation of millennials and that are expected to experience growth in the next 5 years. The millennial generation usually refers to the demographic population that were born between 1980 to 2000. The Millennials Best theme has 77 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Millennials Best Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Exact Stock
To fully project Exact Therapeutics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Exact Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Exact Therapeutics' income statement, its balance sheet, and the statement of cash flows.